With over two decades dedicated to biologics operations, I’ve honed my expertise through leadership roles at industry-leading companies like Astellas, Bristol-Myers Squibb, Amgen, AbbVie and Abbott Laboratories. My career has been defined by a relentless pursuit of operational excellence, driving significant growth and cost reductions for biologics operations.

I excel in translating strategic visions into tangible results. My core competencies in strategic planning, lean methodologies, technology transfer, and regulatory affairs have been instrumental in optimizing complex operations. I’ve successfully led the commercialization of several critical therapies, such as AdceTris®, Imlygic®, and Opdivo®, and established state-of-the-art manufacturing facilities.

Specific project highlights include spearheading a technology transfer initiative that reduced cycle time by 45%, implementing lean manufacturing principles to achieve a 30% reduction in errors, and leading a capital project to expand manufacturing capacity by 25%. These accomplishments, among others, demonstrate my ability to deliver measurable results and drive operational excellence.

My passion for process improvement and team development has fostered high-performing organizations capable of delivering exceptional results. I thrive on navigating complex challenges, implementing innovative solutions, and exceeding expectations. With a proven track record of success, I am confident in my ability to contribute meaningfully to any organization seeking to excel in the dynamic biopharmaceutical landscape.

By leveraging my expertise, I can offer tailored consulting services to help organizations enhance operational efficiency, mitigate risks, and achieve regulatory compliance. Whether it’s optimizing processes, implementing new technologies, or addressing complex challenges, I am committed to delivering exceptional results and driving sustainable growth.